Thomas M. Moriarty - 10 May 2021 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role: EVP & General Counsel
Signature: /s/ Thomas M. Moriarty
Issuer symbol: CVS
Transactions as of: 10 May 2021
Net transactions value: -$2,604,268
Form type: 4
Filing time: 12 May 2021, 17:30:16 UTC
Next filing: 23 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CVS	Common Stock	Options Exercise	$6,810,066	+109,469		$62.21	109,469	10 May 2021	Direct
transaction	CVS	Common Stock	Sale	$9,414,334	-109,469	-100%	$86.00	0	10 May 2021	Direct	F1
holding	CVS	Common Stock						81,179	10 May 2021	By GRAT
holding	CVS	Common Stock (restricted)						8,008	10 May 2021	Direct
holding	CVS	Stock Unit						45,748	10 May 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CVS	Stock Option	Options Exercise	$0	-109,469	-75%	$0.000000	36,490	10 May 2021	Common Stock	109,469	$62.21	Direct	F2
holding	CVS	Stock Option						51,361	10 May 2021	Common Stock	51,361	$102.26	Direct	F3
holding	CVS	Stock Option						71,696	10 May 2021	Common Stock	71,696	$104.82	Direct	F4
holding	CVS	Stock Option						125,224	10 May 2021	Common Stock	125,224	$78.05	Direct	F5
holding	CVS	Stock Option						101,004	10 May 2021	Common Stock	101,004	$54.19	Direct	F6
holding	CVS	Stock Option						147,837	10 May 2021	Common Stock	147,837	$58.34	Direct	F7, F8
holding	CVS	Stock Option						155,495	10 May 2021	Common Stock	155,495	$74.30	Direct	F9

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	All sales were effected pursuant to a Rule 10b5-1 plan.
F2	Option became exercisable in four equal annual installments, commencing 4/1/2019.
F3	Option became exercisable in four equal annual installments, commencing 4/1/2016.
F4	Option became exercisable in four equal annual installments, commencing 4/1/2017.
F5	Option became exercisable in four equal annual installments, commencing 4/3/2018.
F6	Option became exercisable in four equal annual installments, commencing 4/1/2020.
F7	The number of shares subject to the option were calculated using a 30-day average price.
F8	Option became exercisable in four equal annual installments, commencing 4/1/2021.
F9	Option becomes exercisable in four equal installments, commencing 4/1/2022.